Abstract | OBJECTIVE: METHODS: RESULTS: In both patients an improvement in the clinical manifestations ( purpura and peripheral neuropathy), laboratory results (serum transaminases and cryocrit), and liver histology was seen, as well as the disappearance of bone marrow B-cell lymphoproliferation. CONCLUSION:
Cyclosporine may be useful in the treatment of type II mixed cryoglobulinemia with prominent autoimmune clinical manifestations, although further studies are needed to better define the selection of patients.
|
Authors | M Ballarè, F Bobbio, S Poggi, G Bordin, M C Bertoncelli, E Catania, A Monteverde |
Journal | Clinical and experimental rheumatology
(Clin Exp Rheumatol)
1995 Nov-Dec
Vol. 13 Suppl 13
Pg. S201-3
ISSN: 0392-856X [Print] Italy |
PMID | 8730507
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antirheumatic Agents
- RNA, Viral
- Cyclosporine
|
Topics |
- Antirheumatic Agents
(therapeutic use)
- Cryoglobulinemia
(complications, drug therapy, virology)
- Cyclosporine
(therapeutic use)
- Female
- Hepacivirus
(genetics)
- Humans
- Italy
- Middle Aged
- Pilot Projects
- Purpura
(complications, drug therapy)
- RNA, Viral
(analysis)
|